Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures how long your blood takes to clot using the prothrombin time method after removing heparin from the sample. Heparin can interfere with clotting tests and make the result look longer than it truly is. In the laboratory, your plasma is treated with a heparin-neutralizing agent or adsorbent so the measurement reflects your own clotting proteins rather than the effect of heparin.
The result helps assess the extrinsic and common pathways of coagulation, which depend on clotting proteins made in the liver and supported by vitamin K. It is typically used when you are receiving heparin, when the blood was drawn from a line that contains heparin, or when clinicians need a truer prothrombin time despite heparin in the circulation.
Doctors use this test to evaluate bleeding or clotting risk, to check liver-related clotting function, and to guide care before procedures when heparin is present. By removing heparin’s effect, it can uncover whether a prolonged routine prothrombin time is due to a genuine problem with clotting proteins, a vitamin K issue, or simply medication interference.
It may be ordered if you are on a heparin infusion, recently received a heparin bolus, or the sample might have been contaminated by a heparinized catheter. It can also help with transitions between anticoagulants or when starting therapy that is interpreted with the prothrombin time and INR. Using the heparin-adsorbed result can reduce unnecessary delays, transfusions, or procedure cancellations that stem from falsely abnormal results.
A higher prothrombin time generally means your blood is taking longer to clot, which can occur with low levels or reduced function of certain clotting proteins, liver dysfunction, vitamin K deficiency, or some medications. A lower value usually means clotting occurred more quickly than expected, which may reflect biological variation or reagent differences across laboratories.
Your clinician will interpret your result alongside your medicines, clinical history, and other tests such as INR, activated partial thromboplastin time, fibrinogen, and a liver panel. If the heparin-adsorbed result remains abnormal, you may need additional testing, a medication review, or vitamin K assessment. Do not stop or change any anticoagulant or supplement without medical advice. If you have bleeding, bruising, or planned procedures, contact your care team to discuss next steps.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
The timing and amount of heparin you received can leave residual drug in the sample. Adsorption greatly reduces interference, but very high concentrations may still have some impact.
Samples taken from a catheter that was flushed with heparin can be contaminated. Using a discard volume and proper flushing helps; a peripheral vein draw is preferred when possible.
Direct oral anticoagulants and warfarin can change prothrombin time. Heparin adsorption does not neutralize these agents, so your medication list and timing of doses are important.
Underfilled citrate tubes, clotted samples, or very high hematocrit can distort results by changing the blood-to-anticoagulant ratio. Proper collection and mixing are essential.
Liver disease and low vitamin K intake or interactions with antibiotics can reduce clotting proteins and prolong clotting time. Nutrition and liver health matter for interpretation.
Physiologic changes in pregnancy and inflammation during acute illness can alter coagulation testing. Your clinician will interpret results in these contexts.
References